Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology an...
The Nasal Sprays is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period. The resear...
The Plasmid is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. The research pr...
The Oxidative Stress Assay for Pharmaceutical is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.2% during th...
The GCC Countries Alzheimer's Disease Patients is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.4% during t...
The Corticosteroid Eyedrops is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period....
The Platelet aggregation reagents is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast p...
The Warfarin Sodium (CAS 129-06-6) is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast ...
Percutaneous nephrolithotomy (PCNL) is the surgical standard for treating large or complex renal stones.
The Percutaneous Nephrolithotomy System is expected to grow from USD XX...
The Life Science Tools & Reagents is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast p...
The Herpes Treatment is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period. The re...
The Hematology Drugs is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period. The re...
The Biosimilar is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. The research...
The Amantadine Hydrochloride (CAS 665-66-7) is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.5% during the ...
The Amantadine Hydrochloride (CAS 665-66-7) is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.8% during the ...
The Glomerulonephritis Treatment is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast pe...
The Glomerulonephritis Treatment is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast pe...
The Clarified Rice Syrup is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period. Th...
The Epoprostenol Sodium FDF is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period....
The Metabotropic Glutamate Receptor 7 is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.9% during the foreca...
We provide more professional and intelligent market reports to complement your business decisions.